Medicine guide
Oxervate
·
- Prescription status not stated
- Eyes and ears
- Active substance
- Cenegermin
- Used in
- Eyes and ears
- Made by
- Dompe' Farmaceutici S.p.A.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Treatment of moderate (persistent epithelial defect) or severe (corneal ulcer) neurotrophic keratitis in adults
From the official label · 2026-09-30 · European Medicines Agency
Details
| Made by | Dompe' Farmaceutici S.p.A. |
|---|---|
| Active substance | Cenegermin |
| Used in | Eyes and ears |
| Classification | S01 · Eyes and ears |
| Orphan medicine | Yes — designated for a rare disease, according to the register |
| Authorised on | 2017-07-06 |
| Last updated by the regulator | 2024-10-25 |
| EMA product number | EMEA/H/C/004209 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).